Ali health's new drug traceability platform

Source: Beijing Times news on May 11, 2016 (reporter Shi Zhijun) two months after the handover of the drug electronic regulatory network system, Ali Health announced the establishment of a new traceability system Yesterday, Ali Health announced that it was preparing to build an open market-oriented third-party drug traceability platform On April 28, the State Food and Drug Administration issued the opinions on further improving the traceability system of food and drugs (Draft for comments), and decided to rebuild the system two months after temporarily suspending the electronic supervision code of drugs Different from the previous mandatory requirement to use Alibaba health's electronic code supervision platform, this draft encourages enterprises to establish their own traceability system According to the opinion draft, the establishment of food and drug traceability system is the main responsibility of the enterprise and an important means to effectively control product safety risks and protect the legitimate rights and interests of consumers This also makes it clear that the main responsibility of the traceability system is transferred from the supervisor to the enterprise If food and drug enterprises do not establish a traceability system, they will be suspected of violating the law At the same time, encourage production and operation enterprises to use information technology to establish food and drug traceability system Encourage information technology enterprises as a third party to provide professional product traceability services for production and operation enterprises Support industry associations to organize enterprises to build traceability information query platform, and promote the interconnection and information sharing of information systems among associations, enterprises and governments The draft also pointed out that the food and drug regulatory authorities at all levels shall not force the food and drug production and marketing enterprises to accept the retroactive services of the designated professional information technology enterprises As a third-party enterprise, alihealth builds the platform according to this clause It is understood that the new traceability platform prepared by alihealth has entered the development period, and the platform version 1.0 is expected to be officially launched in one month The new platform will be fully compatible with the technical standards of "China drug electronic supervision code", and at the same time, it will provide free services for medical institutions and drug enterprises on the original China drug electronic supervision network to enter the new platform In addition, in the next three years, alihealth will not charge basic traceability services such as code sending and flow direction inquiry from the enterprises in residence, but only technical support fees such as data storage and interface call Wang Peiyu, vice president of Alibaba health, said that in the past two years, Alibaba health has invested nearly 100 million yuan in the transformation and upgrading of the drug electronic regulatory network In spite of some doubts and obstructions, Ali's original intention of finding fake medicine "trouble" remains unchanged Wang Peiyu said that unlike before, Alibaba health's new platform as a third party will no longer force enterprises to enter For the vaccine products of enterprises, alihealth will provide permanent free tracing service, in addition, alihealth will also provide permanent free drug flow inquiry service for the public Background: during the two sessions last year, Xie Zilong, chairman of Hunan common pharmacy chain Co., Ltd., questioned the drug supervision code at that time At the end of January this year, Hunan yangtianhe pharmacy sued the State Food and drug administration, believing that it is an administrative violation for the State Food and drug administration to enforce the drug electronic supervision code In addition, 19 pharmacies, including the common people's pharmacy, also issued a joint statement, saying that Ali health's involvement in drug information supervision is not only related to national data security, but also causes unfair competition, and is suspected of kidnapping public rights to use data for profit On February 20, the State Food and Drug Administration issued a decision to temporarily suspend the electronic supervision code of drugs.